Enforcement Can’t Stop Fake Chinese Drugs: Report

Print More

Sign at Shenzhen, China train station mall. Photo by Cory Doctorow via Flickr

No amount of enforcement can stop the torrent of fake drugs and active pharmaceutical ingredients (APIs) coming into the U.S. from China, says the author of a paper forthcoming in the Columbia Science and Technology Law Review.

China is the world's largest supplier of counterfeit pharmaceuticals and APIs, and the source of 79% of all counterfeit drugs seized in the U.S., according to . . .

Want to read more? Please subscribe to The Crime Report!